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Antibiotics are frequently prescribed because of a clinical suspicion
of infection while results of microbiological analysis are still pend-
ing. Empirical therapy may be influenced by microbiological
culture results, either by discontinuation of therapy in the case of
negative cultures, or by broadening or narrowing (streamlining)
the spectrum of antibiotics. Several strategies have been suggested
to improve antibiotic prescribing, such as surveillance of antibiotic
resistance, monitoring and auditing of antibiotics use, the use of
consensus guidelines or computer decision support and improving
multidisciplinary co-operation [1–3].
Although appropriateness of antibiotic prescribing has been
investigated by some [4–6], the impact of microbiological culture
results on antibiotic prescribing has not been analysed frequently
[7,8]. In two longitudinal studies in internal medicine wards,
microbiological analyses were performed in about 70% of all
episodes of infection, relevant micro-organisms were isolated in
about 50% of episodes and this resulted in modification of anti-
biotic therapy in about 50% of the cases [7,9]. In another study,
Arbo et al. reported that cultures obtained within the first 7 days
after admission, and the isolation of Staphylococcus aureus or Gram-
negative bacteria were associated with modification of antibiotic
therapy [8]. We prospectively investigated the impact of mic-
robiological analyses on antibiotic prescribing in three general
internal medicine wards of a Dutch university hospital.
Therapeutic antibiotic prescribing in the general internal
medicine wards (69 beds) at the Maastricht University Hospital
in the Netherlands was prospectively monitored over a 12-
month period, between June 1996 and June 1997. Patients with
HIV-infections and kidney or marrow transplantation were
excluded from the study. Demographic characteristics, types,
dose and route of administration were monitored daily for all
patients receiving antibiotics. The results of microbiological
tests (growth of bacteria and susceptibility testing) and its impact
on antibiotic prescribing was evaluated. The following defi-
nitions were employed.
Infection episode and antibiotic episode: an episode of infec-
tion was defined as a documented or suspected episode of
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infection for which antibiotic therapy was started. An episode
of antibiotic use was defined as the individual time span use of
prescription of one or more antibiotics for the treatment of an
infection episode (adjustment of therapy was not considered a
new episode).
Microbiological evaluation: this included microbiological
cultures obtained from patients receiving antibiotics.
Antibiotic use: antibiotic use was expressed as the number of
episodes per patient and the number of antibiotic-days (i.e. the
total number of days that antibiotics were prescribed divided
by the total number of patient days).
Site of infection: five groups of infections were distinguished:
respiratory tract infections (RTI), urinary tract infections (UTI),
abdominal infections (cholangitis, peritonitis, pancreatitis and
gastro-enteritis), infections of skin and soft tissues, and a mis-
cellaneous group (bacteraemia, catheter-related infections and
fever of unknown origin).
Community- and hospital-acquired infection: an episode of
infection was considered community-acquired when infection
was presumed and antibiotic therapy was started within 48 h
after admission. Infections occurring after this time point were
considered hospital-acquired.
Adjustment of therapy: this was defined as changing antibiotic
therapy based on the in vitro susceptibility results of microbiological
analysis [e.g. the isolated bacteria was resistant to the empirical
therapy or the antibiotic spectrum could be narrowed].
During the study, there were 262 episodes of antibiotic
therapy in 249 patients (111 males and 138 females). Most
patients (n = 238, 96%) received one episode of antibiotic ther-
apy, nine patients received two episodes and two patients
received three episodes. The median age of the patients was 77
years (range 20–101 years). The overall mortality was 10%
(n = 25). The median hospital stay in the wards was 14 days
(range 1–240 days).
Most infections (n = 185, 71%) were community-acquired,
and UTI (n = 94, 36%) and RTI (n = 93, 35%) accounted for
the majority of infections (Table 1).
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Table 1 Site of infection
Community-acquired Hospital-acquired
Site of infection (n = 185) (n = 77)
Urinary tract 55 39
Respiratory tract 69 24
Intra-abdominal 33 2
Skin and soft tissues 12 1
Miscellaneous 16 11
Table 2 Number of micro-
organisms isolated from patients
receiving antibiotics
Isolated Isolated
Micro-organism from blood from other sites
Enterobacteriaceae
Escherichia coli 19 52
Klebsiella oxytoca 5 10
Klebsiella pneumoniae 2 5
Enterobacter cloacae 3
Enterobacter agglomerans 1
Proteus mirabilis 1 5
Proteus vulgaris 2
Morganella morganii 2
Citrobacter freundii 1
Salmonella group D 1 1
Other Gram-negative bacteria
Haemophilus influenzae 11
Pseudomonas aeruginosa 3 6
Moraxella catarrhalis 1
Gram positive bacteria
Staphylococcus aureus 5 15
Coag. Negative Staphylococcus 10
Enterococcus species 10
Streptococcus pneumoniae 2 10
other Streptococci 5 5
Corynebacterium species 2
Anaerobic bacteria
Prevotella oralis 1
Clostridium perfringens 1
Bacteroides fragilis 1
Yeasts
Candida albicans 1
Enterobacteriaceae accounted for 55% (110 of 199) of all
isolates and were most prevalent both in blood cultures as well
as in cultures from other sites. Escherichia coli accounted for 68%
(19 of 28) and 63% (52 of 82) of all positive cultures with
Enterobacteriaceae in cultures from blood and other sites,
respectively. Staphylococcus aureus was the most frequently iso-
lated pathogen among Gram-positive bacteria, and accounted
for 21% (five of 24) and 38% (15 of 40) of all positive cultures
with Gram-positive bacteria in cultures from blood and other
sites, respectively (Table 2).
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Antibiotic therapy was started empirically in 226 episodes
and prescribing was initiated following relevant culture growth
in 36 episodes.
Microbiological tests were performed in 237 (90%) episodes
of antibiotic prescription (Figure 1). Relevant micro-organisms
were cultured in 137 (52%) episodes. In the remaining 100
episodes (42%) there was no bacterial growth or no relevant
pathogenic bacteria were isolated, and this resulted in dis-
continuation of therapy in 11 (11%) episodes. In case of relevant
growth of micro-organisms in cultures (n = 137), antibiotic
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Figure 1 Microbiological investigations and the effects on antibiotic prescription.
therapy was initiated in 36 cases (26%), streamlining of therapy
was possible in 75 cases (55%), and adjustment was not recom-
mended in 26 cases (19%). In those case for which streamlining
was possible (n = 75), adjustment of therapy occurred in 29
cases (39%). In most cases empirical therapy was narrowed in
spectrum (n = 20) and in nine cases, the antibiotic spectrum had
to be extended because isolated pathogens were not susceptible
to empirical treatment.
In summary, antibiotic prescription was influenced by micro-
biological analysis in 76 of 237 cases (32%); 11 times resulting
in discontinuation of therapy, 36 times resulting in initiation
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of therapy and 29 times resulting in adjustment of empirical
therapy.
Isolation of S. aureus resulted in adjustment of therapy in
58% (seven of 12) of episodes as compared with 29% (20 of 70)
in case of isolation of Gram-negative rods and 11% (two of 19)
in case of isolation of other pathogens (P = 0.02). Micro-
biological cultures obtained during the first 7 days resulted in
adjustment of therapy in 30% of episodes (26 of 88) versus 23%
(three of 13) of episodes when microbiological cultures were
obtained after 7 days (P = 0.6). Adjustment of therapy occurred
with comparable frequency in community- and hospital-
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Table 3 Number of antibiotic prescriptions in 262 episodes of
infection
Antibiotic No. of prescriptions
Amoxicillin + clavulanic acid 148
Gentamicin 67
Amoxycillin 31
Norfloxacin 25
Piperacillin 24
Flucloxacillin 11
Other antibiotics 36
NB 72 patients received two antibiotics.
acquired episodes of infection; 30 and 24%, respectively
(P = 0.6). Positive blood culture results were not more fre-
quently associated with adjustment of therapy than positive site
culture results, namely 29% (12 of 42) and 27% (16 of 59),
respectively (P = 1).
Amoxicillin + clavulanic acid and gentamicin were the anti-
biotics most frequently prescribed, in 148 (56%) and 67 (26%)
episodes, respectively (Table 3).
This study describes the impact of microbiological culture
results on antibiotic prescribing. Our data show that, although
microbiological analysis had been performed in 90% of all epi-
sodes of infection, antibiotic prescribing was only influenced
by microbiological culture results in 32% of the cases. In cases
of positive cultures, streamlining of empiric therapy occurred
in 39% of all possible cases. Negative culture results led to
discontinuation of therapy in only 11% of the cases. We do not
propose to always discontinue antibiotic therapy when cultures
remain negative. But 11% seems to be a very low percentage
and it is our impression that antibiotics could be discontinued
more often. However, to the best of our knowledge, data from
other studies on this issue are lacking.
Few data have been generated about the impact of micro-
biological culture results on antibiotic prescribing [8]. Our
findings that microbiological culture results were performed in
90% of episodes of antibiotic prescription and that relevant
bacterial growth occurred in 58% of these cases confirm pre-
vious observations. Gyssens and co-workers found, in two study
periods and also in general medicine wards in a university
hospital in the Netherlands, that microbiological analysis was
performed in 76–83% of all episodes of antibiotic prescription,
that relevant micro-organisms were isolated in 59–69% and that
antibiotic therapy was changed in approximately 50% of these
cases [9]. In a British district general hospital microbiological
tests were carried out in 67% of all episodes of infection and
relevant bacteria were isolated in 47% [7]. In that study, results
of microbiological cultures resulted in modification of therapy
in 67% of the cases, mostly because therapy was started upon
positive cultures.
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Arbo et al. identified factors that correlate with therapy modi-
fication [8]. They found that cultures that were obtained in the
first 7 days after admission and the isolation of S. aureus or a
Gram-negative bacillus from blood correlated with frequent
antibiotic modification. We also found that isolation of S. aureus
was frequently followed by adjustment of therapy. However,
we failed to show that cultures obtained within the first 7
days of admission and isolation of Gram-negative bacilli were
associated with adjustment of antibiotic therapy.
In conclusion our data show that antibiotic prescribing is
infrequently influenced by microbiological culture results.
However, this does not imply that microbiological inves-
tigations are not essential in the diagnostic process when infec-
tion is suspected. During the study period there were no regular
contacts between infectious disease specialists and physicians on
the wards. A daily review of the microbiological results of
patients receiving antibiotics by an infectious disease specialist
may be an effective approach to integrate microbiological results
into medical practices and to improve antibiotic prescribing
[10]. In addition, education, formulary restriction, pharmacy
justification, formulary substitution, computer surveillance, lab-
oratory item cost listing, purchase plans, and multidisciplinary
approaches have been used successfully to control antimicrobial
costs [3].
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